Theravance Biopharma (TBPH) EBIT (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Theravance Biopharma | 823.54 Mn | 428.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -147.39% |
| Dec 31, 2025 | 410.02% |
| Sep 30, 2025 | -136.88% |
| Jun 30, 2025 | 81.12% |
| Mar 31, 2025 | -56.89% |
| Dec 31, 2024 | 15.11% |
| Sep 30, 2024 | 31.00% |
| Jun 30, 2024 | -40.14% |
| Mar 31, 2024 | -79.60% |
| Dec 31, 2023 | 28.77% |
| Sep 30, 2023 | 45.67% |
| Jun 30, 2023 | 35.28% |
| Mar 31, 2023 | -42.91% |
| Dec 31, 2022 | -90.64% |
| Sep 30, 2022 | 65.98% |
| Jun 30, 2022 | 30.19% |
| Mar 31, 2022 | 31.45% |
| Dec 31, 2021 | -4.76% |
| Sep 30, 2021 | 16.37% |
| Jun 30, 2021 | 23.58% |
| Mar 31, 2021 | -9.68% |
| Dec 31, 2020 | 0.16% |
| Sep 30, 2020 | -6.15% |
| Jun 30, 2020 | 0.41% |
| Mar 31, 2020 | -2.70% |
| Dec 31, 2019 | -8.24% |
| Sep 30, 2019 | -53.50% |
| Jun 30, 2019 | 42.34% |
| Mar 31, 2019 | -17.64% |
| Dec 31, 2018 | -0.27% |
| Sep 30, 2018 | -28.22% |
| Jun 30, 2018 | 25.04% |
| Mar 31, 2018 | 17.93% |
| Dec 31, 2017 | -38.91% |
| Sep 30, 2017 | 12.48% |
| Jun 30, 2017 | -10.70% |
| Mar 31, 2017 | -1.72% |
| Dec 31, 2016 | -72.67% |
| Sep 30, 2016 | 29.48% |
| Jun 30, 2016 | -14.06% |
| Mar 31, 2016 | 25.34% |
| Dec 31, 2015 | -29.42% |
| Sep 30, 2015 | 4.85% |
| Jun 30, 2015 | -20.02% |
| Mar 31, 2015 | 42.61% |
| Dec 31, 2014 | -31.34% |
| Sep 30, 2014 | 11.72% |
| Jun 30, 2014 | 5.52% |
| Mar 31, 2014 | -36.16% |
| Dec 31, 2013 | -7.31% |
| Sep 30, 2013 | -5.46% |
| Jun 30, 2013 | -21.07% |